Page 1 | Search Results | Blood | American Society of Hematology

1-5 of 5

Sort by

Sort Order Select

Journal Articles

Bortezomib, Dexamethasone and Rituximab in Newly Diagnosed Patients with WaldenströM's Macroglobulinemia: Final Analysis of a Phase 2 Study after a Minimum Follow up of 6 Years

Maria Gavriatopoulou, Ramon Garcia-Sanz, Efstathios Kastritis, MD, Pierre Morel, Marie-Christine Kyrtsonis, MD PhD, Evridiki Michalis, Zafeirios Kartasis, Xavier Leleu, Giovanni Palladini, MD PhD, Alessandra Tedeschi, Dimitra Gika, Giampaolo Merlini, MD, Pieter Sonneveld, Meletios A Dimopoulos

Blood (2016) 128 (22): 2957.

https://doi.org/10.1182/blood.V128.22.2957.2957

Published: 2016

Journal Articles

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Efstathios Kastritis, Maria Gavriatopoulou, Marie-Christine Kyrtsonis, Maria Roussou, Evdoxia Hadjiharissi, Argyris Symeonidis, Panagiotis Repoussis, Evridiki Michalis, Sosana Delimpasi, Konstantinos Tsatalas, Panagiotis Tsirigotis, Amalia Vassou, Elina Vervessou, Eirini Katodritou, Dimitra Gika, Evangelos Terpos, Meletios A. Dimopoulos

Blood (2015) 126 (11): 1392–1394.

https://doi.org/10.1182/blood-2015-05-647420

Published: 2015

Includes: Supplemental data

Journal Articles

Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS).

Athanasios G. Galanopoulos, MD, PhD, Stephanos Papadhimitriou, MD, Ioannis Tsourveloudis, MD, Evridiki Michalis, MD, Theodoros Marinakis, MD, PhD, Anastasia Tsakiridou, MD, Ioanna Savvidou, MD, Vasilios Xanthopoulos, MD, George Theodoropoulos, MD, George Gortzolidis, MD, Athanasios Zomas, MD, Maria Georgiakaki, MD, Nikolaos I. Anagnostopoulos, MD, PhD

Blood (2005) 106 (11): 4907.

https://doi.org/10.1182/blood.V106.11.4907.4907

Published: 2005

Journal Articles

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Theodoros P. Vassilakopoulos, MD, Maria K. Angelopoulou, MD, Zacharoula Galani, MD, Sotirios Sachanas, MD, Andreas Katsigiannis, MD, Maria N. Dimopoulou, MD, Styliani I. Kokoris, MD, Evridiki Michalis, MD, Evangelia M. Dimitriadou, MD, Marina P. Siakantaris, MD, Flora N. Kontopidou, MD, Christina Kalpadakis, MD, Angelos Sarantopoulos, MD, Pinelopi Korkolopoulou, MD, Paraskevi Roussou, MD, Gerassimos A. Pangalis, MD

Blood (2005) 106 (11): 935.

https://doi.org/10.1182/blood.V106.11.935.935

Published: 2005

Journal Articles

Early Mortality of Newly Diagnosed Adult Acute Promyelocytic Leukemia Treated with the AIDA Protocol.

George Gortzolidis, Athanasios Zomas, Theodore Marinakis, Evridiki Michalis, Athanasios Galanopoulos, Vasiliki Grigoraki, John Tsourveloudis, Anastasia Tsakiridou, Freda Passam, Nikolaos I. Anagnostopoulos

Blood (2005) 106 (11): 4617.

https://doi.org/10.1182/blood.V106.11.4617.4617

Published: 2005

NARROW

Bortezomib, Dexamethasone and Rituximab in Newly Diagnosed Patients with WaldenströM's Macroglobulinemia: Final Analysis of a Phase 2 Study after a Minimum Follow up of 6 Years

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS).

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Early Mortality of Newly Diagnosed Adult Acute Promyelocytic Leukemia Treated with the AIDA Protocol.

Email alerts

ASH Publications

American Society of Hematology

Bortezomib, Dexamethasone and Rituximab in Newly Diagnosed Patients with WaldenströM's Macroglobulinemia: Final Analysis of a Phase 2 Study after a Minimum Follow up of 6 Years

Dexamethasone, rituximab, and cyclophosphamide as primary treatment of Waldenström macroglobulinemia: final analysis of a phase 2 study

Deletion of Tumor Suppressor Genes (TSGS) in Patients with Myelodysplastic Syndrome (MDS).

Excellent Outcome with Rituximab-CHOP (R-CHOP) Combined with Radiotherapy (RT) in Primary Mediastinal Large B-Cell Lymhoma (PMLBCL).

Early Mortality of Newly Diagnosed Adult Acute Promyelocytic Leukemia Treated with the AIDA Protocol.

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only